Copy to clipboard 
SK Capital Partners completed the previously announced acquisition of LISI Group’s Medical division. The transaction closed on October 31, 2025.
The business has relocated its headquarters to Big Lake, Minnesota and has been renamed Precera Medical, serving as a global contract development and manufacturing organization partner for medical device OEMs. As part of the transaction, LISI Group retained a minority stake in the Company.
Precera Medical is focused on the production of high-precision components and assemblies. The company transforms designs into manufacturable solutions for applications including surgical robotics, orthopedics, and more. Precera Medical operates four manufacturing sites, two in Minnesota, and two in France, with expertise in development, rapid prototyping, precision machining, precision forging and highly automated production.
Precera Medical expanded its executive leadership team with the appointment of CDMO industry veteran Dylan Hushka as CEO. Hushka has held C-level, executive, commercial, and engineering roles at Spectrum Plastics Group, Nordson Medical, Vention Medical, IMDS, and Covidien (Medtronic).
Further, the company’s Advisory Board includes Art Burghouwt, former EVP of Sales, Marketing & Business Development at Tecomet; and Brian Hutchison, former CEO of RTI Surgical, among others.
Dylan Hushka said, “I am proud to join the Precera Medical team and, as a former customer, have been impressed by Precera’s world-class engineering, manufacturing, automation, quality assurance, and customer focus. With more than 75 years of contract development and manufacturing excellence, Precera continues to innovate and invest in enabling market-leading medical device OEMs to launch breakthrough technologies that impact millions of patients each year.”
Source: SK Capital
